Country: Irlanda
Lingwa: Ingliż
Sors: HPRA (Health Products Regulatory Authority)
ACICLOVIR
Winthrop Pharmaceuticals UK Limited
800mg Milligram
Tablets
1999-07-07
PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Aciclovir 800mg Dispersible Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains Aciclovir 800mg. For excipients, see 6.1. 3 PHARMACEUTICAL FORM Dispersible tablet White oval dispersible tablet with S95 embossed on one side and scored on the reverse. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Aciclovir Tablets are indicated for the treatment of varicella (chickenpox) and herpes zoster (shingles) infections. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _TREATMENT OF VARICELLA AND HERPES ZOSTER INFECTIONS_ 800mg aciclovir should be taken five times daily at approximately four-hourly intervals, omitting the night time dose. Treatment should continue for seven days. In severely immunocompromised patients (e.g. after marrow transplant) or in patients with impaired absorption from the gut consideration should be given to intravenous dosing. Dosing should begin as early as possible after the start of an infection: Treatment of herpes zoster yields better results if initiated as soon as possible after the onset of the rash. Treatment of chicken pox in immunocompetent patients should begin within 24 hours after onset of the rash. CHILDREN _TREATMENT OF VARICELLA INFECTIONS_ 6 years and over 800mg aciclovir four times daily. 2 to five years 400mg aciclovir four times daily. Under 2 years 200mg aciclovir four times daily. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 23/11/2006_ _CRN 2030408_ _page number: 1_ Treatment should continue for five days. Dosing may be more accurately calculated as 20mg/kg bodyweight (not to exceed 800mg) aciclovir four times daily. No specific data are available on the suppression of Aqra d-dokument sħiħ